- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05269836
Use of Surgify Safety Burr in Hard Tissue Cutting, Head and Spine Area
November 29, 2022 updated by: Nuutti Vartiainen, Surgify Medical Oy
Surgify2021. Use of Surgify Safety Burr in Hard Tissue Cutting, Head and Spine Area.
Purpose of the study: To evaluate whether the SSB is safe, useful, beneficial and effective in drilling, cutting and removal of bone tissue in neurosurgical and spine procedures.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Sponsored observational clinical pilot study with no control group.
Aim is to get a maximum of 20 study subjects, who have disease of the spine or head requiring surgery with bone removal and who are willing to participate into this study.
Study Type
Observational
Enrollment (Actual)
22
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Helsinki, Finland, 00290
- HUS,Töölö hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 70 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
Any 18 to 70 -year old patient scheduled to back/head operation can be recruited according to other inclusion and exclusion criteria.
Description
Inclusion Criteria:
- Disease of the spine or head requiring surgery with bone removal
- Ability to understand the purpose and risks of the study and to give written informed consent
- Age 18-70 years
Exclusion Criteria:
- Previous surgery on the same area
- Abnormalities of bone tissue
- Vulnerable patient (such as prisoner, retarded person, person in nursing home, patient in emergency situation)
- Allergy or hypersensitivity to medical-grade stainless steel or any of alloying components
- Problems with blood clotting
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Case-Only
- Time Perspectives: Other
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
To evaluate usability of SSB
Time Frame: Duration is from recruitment until end of the time on recovery ward, approximately 1 day to 1 week.
|
Using video material from operations, microphone recording of the surgeon commentary during drilling and questionnaires to surgeon.
|
Duration is from recruitment until end of the time on recovery ward, approximately 1 day to 1 week.
|
|
To evaluate safety of SSB
Time Frame: Duration is from recruitment until end of the time on recovery ward, approximately 1 day to 1 week.
|
AE reporting
|
Duration is from recruitment until end of the time on recovery ward, approximately 1 day to 1 week.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
To evaluate effectiveness of SSB
Time Frame: Duration is from recruitment until end of the time on recovery ward, approximately 1 day to 1 week.
|
Using video material from operations, microphone recording of the surgeon commentary during drilling
|
Duration is from recruitment until end of the time on recovery ward, approximately 1 day to 1 week.
|
|
To evaluate beneficiality of SSB
Time Frame: Duration is from recruitment until end of the time on recovery ward, approximately 1 day to 1 week
|
Questionnaires to surgeon
|
Duration is from recruitment until end of the time on recovery ward, approximately 1 day to 1 week
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Nuutti Vartiainen, MD, PhD, HUS
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 14, 2022
Primary Completion (Actual)
October 13, 2022
Study Completion (Actual)
November 17, 2022
Study Registration Dates
First Submitted
January 25, 2022
First Submitted That Met QC Criteria
February 25, 2022
First Posted (Actual)
March 8, 2022
Study Record Updates
Last Update Posted (Actual)
November 30, 2022
Last Update Submitted That Met QC Criteria
November 29, 2022
Last Verified
November 1, 2022
More Information
Terms related to this study
Other Study ID Numbers
- Surgify2021
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Surgery
-
MedtronicCompletedThoracic Surgery | Spine Surgery | Upper Extremity Surgery | Lower Extremity Surgery | Intracranial Surgery | Extracranial Surgery | Intratemporal Surgery | Extratemporal Surgery | Neck SurgeryGermany
-
[Redacted]3M; Solventum US LLCWithheldAbdominal Surgery | Orthopedic Surgery | Vascular Surgery | Cardiovascular SurgeryUnited States
-
Vanderbilt UniversityCompletedHand Surgery | Wrist Surgery | Forearm Surgery | Elbow SurgeryUnited States
-
Nantes University HospitalCompletedGynecological Surgery | Plastic Surgery | ENT SurgeryFrance
-
Edwards LifesciencesCompletedAbdominal Surgery | Pelvic Surgery | Non-Cardiac/ Non-Thoracic Surgery | Major Peripheral Vascular SurgeryUnited States
-
Centre Hospitalier Universitaire de NīmesNot yet recruitingAnesthesia, Local | Foot Surgery | Hand Surgery | Walant SurgeryFrance
-
Eurosets S.r.l.RecruitingCardiac Surgery | Cardiopulmonary Bypass | Heart Surgery | Aortic Valve Surgery | Cannulation | Coronary Surgery With Cardiopulmonary Bypass | Coronary Surgery | Arterial Cannulation | Venous CannulationItaly
-
Baylor Research InstituteChiesi USA, Inc.CompletedSurgery | Cardiac Surgery | Surgery--Complications | Percutaneous Coronary InterventionUnited States
-
Maquet Cardiopulmonary GmbHNAMSATerminatedCardiac Surgery | Cardiopulmonary Bypass | Thoracic Surgery | Vascular SurgerySpain, Italy
-
Vanderbilt UniversityEdwards LifesciencesCompletedCardiac Surgery | Thoracic Surgery | Heart Surgery | Heart Transplant
Clinical Trials on Surgify Safety Burr
-
Services Institute of Medical Sciences, PakistanCompleted
-
Ataturk Training and Research HospitalCompletedSubdural Hematoma, ChronicTurkey
-
Huashan HospitalShanghai Shen Kang Hospital Development Center; Shanghai Municipal Health CommissionActive, not recruitingSubdural Hematoma, Non-acuteChina
-
Surgify Medical OyNorth Shore University HospitalRecruiting
-
St. Olavs HospitalKarolinska Institutet; University Hospital of North Norway; Norwegian University...CompletedHematoma, Subdural, ChronicNorway, Sweden
-
Second Affiliated Hospital, School of Medicine,...RecruitingHematoma, Subdural, ChronicChina
-
Universitair Ziekenhuis BrusselCompletedChronic Subdural HematomaBelgium
-
University of ZurichStryker European Operations BVCompletedHematoma, Subdural, Chronic | Hematoma, Subdural, Intracranial | Haematoma;Subdural;TraumaticSwitzerland
-
Beijing Tiantan HospitalRecruitingChronic Subdural HematomaChina